Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 38 | 30 | −8 |
| Shares | 18.7M | 18.3M | −329.2K (−1.8%) |
| Value | $9.99M | $7.33M | −$2.66M (−26.6%) |
New holders (2)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 21,733 | $8.69K | 0.00% |
| StoneX Group Inc. | 15,532 | $6.21K | 0.00% |
Sold out (10)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 78,961 | $42.3K |
| Engineers Gate Manager LP | 72,402 | $38.7K |
| Bridgeway Capital Management, LLC | 60,200 | $32.2K |
| Goldman Sachs Group Inc | 50,020 | $26.8K |
| Velan Capital Investment Management LP | 50,000 | $26.8K |
| Millennium Management LLC | 47,025 | $25.2K |
| Jane Street Group, LLC | 41,868 | $22.4K |
| Virtu Financial LLC | 29,552 | $16.0K |
| Assenagon Asset Management S.A. | 20,785 | $11.1K |
| Advisor Group Holdings, Inc. | 2,355 | $1.27K |